AAV Process Analytics Services

In the rapidly evolving field of adeno-associated virus (AAV) manufacturing, the focus is on creating well-defined, robust processing steps backed by fast, reliable, and high-throughput analytical methods to ensure consistent product quality. One of the key challenges in AAV production is the characterization of different AAV serotypes and optimizing the ratio of empty to full capsids. Sartorius BIA Separations experts provide comprehensive analytical support throughout the entire manufacturing process.

Common Challenges in AAV Analytics

  1. Low Resolution: Conventional chromatographic methods only observe empty and full capsids with insufficient resolution between peaks.
  2. Low Purity: Conventional methods for separation, such as chromatography resins, achieve only 70% purity of full capsids.
  3. Incomplete Separation: Earlier conventional approaches only partially separated empty and full capsids.
  4. Lack of Serotype Selectivity: Only a few conventional methods offer serotype selectivity when separating AAVs.
  5. Complex Sample Analysis: Full percentage estimation in the upstream complex samples requires a combination of analytical methods, usually PCR and ELISA.

With Cornerstone services, these common challenges in AAV manufacturing are addressed while providing a solution tailored to specific needs.

Contact Us

Overcoming AAV Analytical Challenges

The enhanced anion exchange (AEX) method in combination with PATfix AAV Switcher delivers a significant improvement over conventional approaches. It allows for better separation between empty and full capsids while also identifying additional subpopulations and impurities.

  • Higher Resolution Between Peaks
    The enhanced AEX method facilitates the detection of various AAV subpopulations, such as empty, full, and partially full capsids. Moreover, it identifies other AAV-related impurities, including aggregates and heavy or overfilled capsids.
  • Improved Purity
    The improved AEX method using monolithic chromatography delivers significantly purer full AAV capsids (90%-95% pure full capsids) compared to the conventional methods.
  • Better Separation of Empty and Full Capsids
    The new method achieves baseline separation between empty and full capsids, as well as some additional capsids, indicating the heterogeneity of AAV samples.
  • Serotype Applicability
    The improved AEX method applies to different AAV serotypes, such as AAV5, AAV8 and AAV9.
  • Complex Sample Analysis Simplified
    PATfix AAV Switcher allows the determination of the empty and full ratio in harvest samples or spent media, based on MALS and FLD signals. FLD works in combination with MALS as it has a higher sensitivity while MALS proves to be more reliable in cases of background noise in the FLD profile.

AAV Capsids Separation is Critical for Advancing Gene Therapies

The Novel AEX method delivers enhanced separation of full (F), empty (E), partially filled (P) capsids and other AAV impurities.

Why Choose Cornerstone AAV Process Analytics Services?

By partnering with Cornerstone AAV Process Analytics Services, the following benefits are offered:

  • Higher resolution between peaks for more accurate subpopulation detection.
  • Significantly improved purity of full AAV capsids (up to 95%).
  • Comprehensive capsid separation with insights into additional capsid types.
  • Serotype versatility across AAV5, AAV8, AAV9, and more.
  • Cutting-edge analytical tools for handling complex AAV samples.

Hear From Our Customers

The PATfix pDNA analytical platform package was helpful in getting the plasmid analysis running with validated protocols built-in the system. We have also been utilising PATfix for the analysis of IVT mRNA with validated protocols provided by Sartorius BIA Separations. We have been getting consistent and reliable results with high-throughput work processes made possible by the at-line implementation of the PATfix platform. I am happy with the system as it is easy to use, reliable and the support provided by the highly knowledgeable team at Sartorius BIA Separations and Sartorius has been excellent. I am looking forward to continuing working with the PATfix platform and the Sartorius BIA Separations team with their ongoing developments in providing high-quality analytical products. – Dae Jong Han, Research Specialist (Analytics), BASE mRNA Facility, Australia.

Read more

“By leveraging the capabilities of PATfix, I can effectively determine the ratio of empty and full capsids in our samples, thus providing valuable insights into their purity values. The software’s integration functions are designed with user-friendliness in mind, making the analysis process seamless and efficient.” – Tony Tavares, PhD | Principal Scientist. Teknova

Read more

BioNet

“We are very pleased to be collaborating with BIA Separations / Sartorius in developing and tech-transferring optimized mRNA vaccine manufacturing processes. When time is of the essence, it is crucial to be able to rely on key partners whilst maintaining the highest level of quality in every aspect of our work. We are also very proud that our team was able to produce two kinds of genetic vaccines (DNA and mRNA) and we look forward to expanding our partnership with the BIA Separations’ team on future projects.” – Hong Thai Pham, CEO, BioNet

Read more

Pharmaron

Working with Sartorius BIA Separations, Pharmaron was able to extend its toolbox of AAV purification solutions, providing multiple-modality options to achieve robust separation of genome-containing (full) from genome-free (empty) viral capsids with high purity and yield for multiple AAV serotypes. During this collaboration, a strong partnership was developed leading to Sartorius BIA separations presenting the work at the second webinar of the Pharmaron Cell and Gene Therapy webinar series. The webinar was entitled “Downstream AAV Production: A Targeted Approach to Optimization”.

Read more

Theriva Biologics

“I highly appreciated the willingness of each expert from different monoliths and various applications to support our work, explain new methods, introduce new approaches, and offer further technical support in our product development. I feel like I can really delve into the depths of product characterization, and I believe I can gain much more data from the PATfix system, which I’m really eager to explore in the future.” – Sonia Celej, Bioprocess Development Specialist, Theriva Biologics

Read more

Ready to Discuss Your Project?

FAQ About Services for AAV Process Analytics

The facilities are located in Ajdovščina, Slovenia. Support for process development is available in modern, fully equipped BSL 1 and 2 facilities. A virtual tour of the laboratories is available.

Analytical testing for impurity profiling and detection, AAV recovery assessments, and different AAV capsid separation in AAV DSP samples is offered. Method development and validation are available for all these services.

The multi-wavelength UV-Vis detector, fluorescence detector, and multi-angle light scattering (MALS) detector monitoring nine angles are used. By using different detectors, detailed sample information is obtained in one analytical run.

The key parameters include the choice of stationary phase (column chemistry), mobile phase composition (e.g., screening of elution salts, elution pH), flow rate, temperature, and gradient elution profiles (e.g., gradient slope).

Consult Our Experts

Our experts would be happy to discuss your project. Fill the contact form below or send us an email to cornerstone@biaseparations.com

    Povpraševanje za izdelek

    Fields marked with * are required!

    0
      0
      Your Cart
      Your cart is emptyReturn to Homepage
        This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.